Radioiodine treatment, ablation, and ophthalmopathy: A balanced perspective

Thyroid

Volumn 7, Issue 2, 1997, Pages 241-245

  Tallstedt, Leif ^a   Lundell, Göran ^b  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE DISEASE; GRAVES DISEASE; HUMAN; PRIORITY JOURNAL; RADIATION HAZARD; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0030995121     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.241     Document Type: Review

References (22)

1. Gorman CA 1983 Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 58:515-519.
2. Wiersinga WM, Smith T, van der Gaag R, Koornneef L 1988 Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 11:615-619.
3. Hamilton RD, Mayberry WE, McConahey WM, Hanson KC 1967 Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodide. Mayo Clin Proc 42:812-818.
4. Barbosa J, Wong E, Doe RP 1972 Ophthalmopathy of Graves' disease. Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs. Arch Int Med 130:111-113.
5. Gwinup G, Elias AN, Ascher MS 1982 Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 247:2135-2138.
6. Calissendorf BM, Söderström M, Alveryd A 1986 Ophthalmopathy and hyperthyroidism, a comparison between patients receiving different antithyroid treatments. Acta Ophthalmol 64:698-703.
7. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease 1989 Am J Ophthalmol 83:725-727.
8. Sridama V, DeGroot LJ 1989 Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 87:70-73.
9. Vázquez-Chávez C, Nishimura Meguro E, Espinosa Said L, Delgado Falfari A, Sáinz de Viteri M 1992 Influencia del tratamiento del hipertiroidismo en el curso del exoftalmos. Rev Inv Clin 44:241-247.
10. Fernández Sánchez JR, Rosell Pradas J, Carazo Martinez O, Torres Vela E, Escobar Jimenez F, Garbin Fuentes I, Vara Thorbeck R 1993 Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80: 1134-1136.
11. Bartalena L, Marcocci C, Bogazzi F, Bruno-Bossio G, Tanda ML, Vanni G, Dell'Unto E, Martino E, Pinchera A 1995 Further studies on the course of Graves' ophthalmopathy following radioactive iodine administration. In: International Thyroid Congress book S-70 (abstract 139).
12. Tallstedt L, Lundell G, Törring O, Wallin G, Ljunggren J-G, Blomgren H, Taube A 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
13. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497.
14. Barth A, Probst P, Bürgi H 1991 Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine. J Endocrinol Invest 14:209-212.
15. 131I treatment protocols for Graves' disease. J Endocrinol Invest 13:111-118.
16. Bauer FK, Catz B 1966 Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol 51:15-22.
17. Werner SC, Feind CR, Aida M 1967 Graves' disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation. N Engl J Med 276:132-137.
18. Boyle IT, Greig WR, Thomson JA, Winning J, McGirr EM 1969 Effect of thyroid ablation on dysthyroid exophthalmos. Proc Roy Soc Med 62:19-23.
19. Volpé R, Desbarats-Schonbaum M-L, Schonbaum E, Row VV, Ezrin CE 1969 The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Am J Med 46:217-226.
20. Catz B, Perzik SL 1969 Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118:434-439.
21. Heufelder AE, Gorman CA, Bahn RS 1991 Modulation of HLA-DR expression on retrocoular fibroblasts from patients with active thyroid-related ophthalmopathy: In vitro effects of agents used in the management of hyperthyroidism and ophthalmopathy. Exp Clin Endocrinol 97:206-211.
22. Heufelder AE, Wenzel BE, Bahn RS 1992 Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts. J Clin Endocrinol Metab 74:737-742.